AxoGen, Inc. provided preliminary unaudited earnings guidance for the fourth quarter and full year ended December 31, 2018. Fourth quarter revenue is expected to be at least $23.4 million, up 38% compared to fourth quarter 2017 revenue of $17.0 million. Full year 2018 revenue is expected to be at least $83.9 million, up 39% compared to 2017 revenue of $60.4 million, reflects this large, diverse customer base, supported by an expanding team of direct sales representatives. Management reiterates that 2019 annual revenue is expected to grow by at least 35% over 2018 revenue and that its gross margin is expected to remain above 80%.